Healthcare -
Biotechnology - NYSE - US
$ 2.425
1.04 %
$ 816 M
Market Cap
-1.11
P/E
NUVB - COST OF REVENUE
Cost of Revenue NUVB - Nuvation Bio Inc.
222 K
LAST VALUE
-22.33%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR